Citation 92357

LEE,SH:. (1974). EFFECT OF VARIOUS CANCER CHEMOTHERAPEUTICS ON EHRLICH ASCITIC TUMOR IN MICE.. 27()

Citation Details

Title	EFFECT OF VARIOUS CANCER CHEMOTHERAPEUTICS ON EHRLICH ASCITIC TUMOR IN MICE.
Authors	LEE,SH:
Year	1974
Volume	27
Issue

Summary

Year: 1974

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
5	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
6	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
7	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
8	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
10	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
11	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
12	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
13	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
14	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
15	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
16	ANTITUMOR ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE

Show SPARQL Queries (1)